Artia Global Partners as of Dec. 31, 2024
Portfolio Holdings for Artia Global Partners
Artia Global Partners holds 35 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novo-nordisk A S Adr (NVO) | 13.8 | $39M | 450k | 86.02 | |
| Soleno Therapeutics | 7.9 | $22M | 494k | 44.95 | |
| Merus N V (MRUS) | 7.0 | $20M | 464k | 42.05 | |
| Intra Cellular Therapies (ITCI) | 6.6 | $18M | 220k | 83.52 | |
| Arcellx Common Stock (ACLX) | 6.3 | $18M | 230k | 76.69 | |
| Nuvalent Inc-a (NUVL) | 5.7 | $16M | 204k | 78.28 | |
| Vaxcyte (PCVX) | 4.7 | $13M | 162k | 81.86 | |
| Alnylam Pharmaceuticals (ALNY) | 4.7 | $13M | 56k | 235.31 | |
| Astrazeneca Sponsored Adr | 4.5 | $13M | 191k | 65.52 | |
| Revolution Medicines (RVMD) | 4.4 | $12M | 284k | 43.74 | |
| Verona Pharma Sponsored Ads (VRNA) | 4.2 | $12M | 255k | 46.44 | |
| Insmed Com Par $.01 (INSM) | 4.1 | $12M | 168k | 69.04 | |
| Protagonist Therapeutics (PTGX) | 4.1 | $11M | 294k | 38.60 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 3.2 | $9.0M | 100k | 90.06 | |
| Janux Therapeutics (JANX) | 3.1 | $8.7M | 163k | 53.54 | |
| Argenx Se Sponsored Adr (ARGX) | 2.5 | $7.0M | 11k | 615.00 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $6.1M | 45k | 136.50 | |
| Viking Therapeutics (VKTX) | 1.3 | $3.6M | 90k | 40.24 | |
| Rhythm Pharmaceuticals (RYTM) | 1.0 | $2.8M | 50k | 55.98 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $2.3M | 46k | 51.13 | |
| Enliven Therapeutics (ELVN) | 0.8 | $2.3M | 103k | 22.50 | |
| Springworks Therapeutics (SWTX) | 0.7 | $1.9M | 54k | 36.13 | |
| Miragen Therapeutics (VRDN) | 0.7 | $1.9M | 100k | 19.17 | |
| Tg Therapeutics (TGTX) | 0.6 | $1.6M | 55k | 30.10 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.6 | $1.6M | 217k | 7.45 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $1.6M | 40k | 39.20 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.5 | $1.5M | 421k | 3.50 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $1.4M | 54k | 25.70 | |
| Centessa Pharmaceuticals Sponsored Ads | 0.5 | $1.3M | 80k | 16.75 | |
| Edgewise Therapeutics Put Option (EWTX) | 0.5 | $1.3M | 50k | 26.70 | |
| Charles River Laboratories (CRL) | 0.4 | $1.2M | 6.3k | 184.60 | |
| Tarsus Pharmaceuticals (TARS) | 0.4 | $1.2M | 21k | 55.37 | |
| Ascendis Pharma A/s Sponsored Adr | 0.4 | $1.0M | 7.4k | 137.67 | |
| Annexon (ANNX) | 0.3 | $884k | 172k | 5.13 | |
| Tectonic Therapeutic (TECX) | 0.3 | $769k | 17k | 46.17 |
